A predominance of small, dense LDL in plasma is predictive of coronary risk' and a hallmark feature of an atherogenic lipoprotein phenotype (ALP).2 The measurement of small, dense LDL (LDL pattern 'B') has traditionally been based on the separation of LDL subclasses by density gradient ultra-centrifugation and gradient gel electrophoresis. However, these techniques are expensive, time consuming and unsuitable for routine applications and the screening of large cohorts. While more rapid procedures are currently under development, it is possible to gain information on the nature of LDL subclasses by measuring the ratio of plasma apolipoprotein(b) [apo(b)] to LDL cholesterol (LDL-C),3 since this will increase as LDL particles become small and dense.
A predominance of small, dense LDL in plasma is predictive of coronary risk' and a hallmark feature of an atherogenic lipoprotein phenotype (ALP). 2 The measurement of small, dense LDL (LDL pattern 'B') has traditionally been based on the separation of LDL subclasses by density gradient ultra-centrifugation and gradient gel electrophoresis. However, these techniques are expensive, time consuming and unsuitable for routine applications and the screening of large cohorts. While more rapid procedures are currently under development, it is possible to gain information on the nature of LDL subclasses by measuring the ratio of plasma apolipoprotein(b) [apo(b)] to LDL cholesterol (LDL-C),3 since this will increase as LDL particles become small and dense.
The aim of this study was to examine the strength of the relationship between the concentration of small, dense LDL as measured by density gradient centrifugation and the ratio of plasma apo(b) to LDL-C, with a view to this ratio acting as a surrogate marker for small, dense LDL.
MATERIALS AND METHODS
Blood samples were collected from normal, healthy subjects (n = 58) who were being screened routinely for plasma LDL subclasses. The subjects (56 men, 2 women, aged 20-60 years) were pre-selected for the presence of moderately raised plasma triglyceride (TO), with or without moderately raised plasma cholesterol, for participation in dietary intervention studies. All subjects were free-living, non-smoking, nonobese and free of medication known to affect lipid metabolism. LDL subclasses were determined at the University of Surrey by density gradient centrifugation" and the LDL subclass was analysed by means of the 'i test. Factors contributing to variation in % LDL-II1 were determined by simple linear and stepwise regression. Sensitivity and specificity were determined with 95% confidence intervals (shown in brackets) as measures of diagnostic accuracy."
RESULTS
In the total group 76% expressed LDL pattern 'B' (LDL-1II>40%), which included subjects with an 'intermediate' LDL subclass pattern, pattern 'I' (% LDL-III =40-50%).2 Data showed expected differences in plasma TO between LDL patterns 'A' and 'B' (1'49 versus 2'90mmoljL, P<O'OI) and HDL-C (1'12 versus 0'89mmol/L, P<O'Ol) and plasma apo(b):LDL-C ratio (0,28 versus 0,23, P<0'05) but no difference in total plasma cholesterol (6'94 versus 6·60 mmol/L), In univariate analysis, total plasma TO, apo(b):LDL-C and HDL-C explained 39% (P<O·OOl), 34% (P<O'OOI) and 26% (P<O·OI) of the variation (,2) in the percentage of small, dense LDL-III, respectively. 
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, , , ..............................; ..... compared with a plasma TG cut-off of 1·5 mmoljL, which classified 95% LDL pattern 'Bs' as true positives (89-101%). The specificity of the apo(b):LDL-C ratio, ability to discriminate true negatives or LDL pattern 'A', was 79% (69-90%) as compared with 59% (44-70%) for plasma TG.
DISCUSSION
This study investigated the relative power of the ratio of plasma apo(b):LDL-C to discriminate between a predominance of small, dense LDL (pattern 'B') and larger, less dense LOL (pattern 'A').
Plasma TG was more sensitive in detecting small, dense LOL (pattern 'B') than was the ratio of plasma apo(b):LOL-C at the clinically recognized threshold of 1·5 mmoljL, but the former was less specific in detecting pattern 'A' than the latter. The ratio showed a stronger and thus more predictive association with LOL pattern '8' in combination with TG than did HOL-C, and was thus selected in preference to HOL-C to explain variation in the abundance of small, dense LDL.
The measurement of plasma apo(b) will have included a variable contribution from non-LOL, apo(b)-containing TG-rich lipoproteins (TGRL). Likewise, the calculation of LOL-C by the Friedewald formula is generally regarded to be invalid above plasma TG values of 4 mmoljL due to interference from TGRL. In the present study, both of these components will have exerted a positive bias on the results by increasing the apo(b):LOL-C ratio as plasma TG increased.
In conclusion, plasma TG was shown to be superior to the plasma apo(b):LOL-C ratio in discriminating the presence of small, dense LDL. Nevertheless, the ratio would seem to provide useful and additional information to HDL-C in predicting LDL pattern '8' under non-fasting conditions when plasma TG is unreliable. The ratio also provides an estimate of the absolute number of LOL particles [plasma apo(b)], which is known to be an independent determinant of coronary risk associated with small, dense LOL.
